Generated by AI
LENSAR Inc. is a commercial-stage medical device company focused on advanced laser systems for cataract surgery and astigmatism management. Its current portfolio centers on the LENSAR Laser System and the ALLY Robotic Cataract Laser System, which combine imaging, planning, and laser-based treatment tools to support surgeons in refractive cataract procedures. The company’s systems are used to help manage key steps of surgery, including treatment planning, precision delivery, and workflow efficiency in clinical settings. LENSAR also provides related consumables, procedure licenses, training, installation, and maintenance services, making its offerings part of a broader surgical platform rather than standalone hardware. Headquartered in Orlando, Florida, LENSAR serves ophthalmic practices and surgical centers in the United States and international markets.
Website2800 Discovery Drive
Orlando, FL, 32826
United States
The latest articles about LNSR.
LENSAR Inc (LNSR) posted 89% recurring revenue mix, 58% gross margin, and positive adjusted EBITDA of $1.7 million, even as total revenue dipped 1% on system sales timing.
Summary of Aug 13's posts. Generated by AI.
No summary yet.
Summary of Aug 13's posts. Generated by AI.
No summary yet.
Summary of Aug 13's posts. Generated by AI.
Investors talking about LNSR also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.